Your session is about to expire
← Back to Search
Other
Mahana Tinnitus Pilot
N/A
Waitlist Available
Research Sponsored by Mahana Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 days
Treatment Varies
Follow Up 3 days
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing Mahana™ Tinnitus, a treatment for people who hear ringing in their ears. It involves about 250 adults who will use the treatment for several weeks. The goal is to see if it helps reduce their tinnitus symptoms.
Eligible Conditions
- Tinnitus
Timeline
Screening ~ 3 days0 visits
Treatment ~ Varies
Follow Up ~ 3 days0 visits
Screening ~ 3 days
Treatment ~ Varies
Follow Up ~3 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean Change in TFI Score From Baseline to Week 6
Tinnitus Functional Index Responder Rate
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MHNA-003Experimental Treatment1 Intervention
MHNA-003 is a self-guided digital program for people living with tinnitus
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MHNA-003
2022
N/A
~100
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Mahana TherapeuticsLead Sponsor
1 Previous Clinical Trials
194 Total Patients Enrolled